Pages that link to "Q54106653"

The following pages link to Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. (Q54106653):

Displaying 42 items.

• Roles of the kidney in the formation, remodeling and repair of bone (Q26768186) (← links)
• Nuclear receptors in bone physiology and diseases (Q26853017) (← links)
• The biology and pathology of vitamin D control in bone (Q33608847) (← links)
• Vitamin d status and spine surgery outcomes (Q33710415) (← links)
• Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction (Q33886695) (← links)
• Osteoclast formation and resorption (Q33936579) (← links)
• Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta (Q34148428) (← links)
• Vitamin D and bone (Q34250790) (← links)
• Vitamin D endocrine system and osteoclasts (Q34408862) (← links)
• Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts (Q34409480) (← links)
• Antiproliferative action of vitamin D. (Q34566267) (← links)
• Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. (Q34621641) (← links)
• Changes in Dickkopf-1 (DKK1) and Sclerostin following a Loading Dose of Vitamin D 2 (300,000 IU). (Q34761795) (← links)
• Chondromodulin I is a bone remodeling factor. (Q34811184) (← links)
• Urinary calcium and oxalate excretion in healthy adult cats are not affected by increasing dietary levels of bone meal in a canned diet (Q34935261) (← links)
• Minireview: nuclear receptor regulation of osteoclast and bone remodeling (Q35054970) (← links)
• Suppressive function of androgen receptor in bone resorption (Q35234694) (← links)
• Vitamin D metabolism: new concepts and clinical implications (Q35754263) (← links)
• 25-Hydroxy- and 1α,25-Dihydroxycholecalciferol Have Greater Potencies than 25-Hydroxy- and 1α,25-Dihydroxyergocalciferol in Modulating Cultured Human and Mouse Osteoblast Activities. (Q36205423) (← links)
• The role of the immune system in the pathophysiology of osteoporosis (Q36324969) (← links)
• Physiological insights from the vitamin D receptor knockout mouse (Q36438095) (← links)
• Mechanism of vitamin D receptor action (Q36532531) (← links)
• Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease (Q36703949) (← links)
• Downregulation of Runx2 by 1,25-Dihydroxyvitamin D₃ Induces the Transdifferentiation of Osteoblasts to Adipocytes (Q36939350) (← links)
• Vitamin D and human health: lessons from vitamin D receptor null mice. (Q36973933) (← links)
• Contributions to osteoclast biology from Japan (Q37038278) (← links)
• Vitamin D Status: Current Opinion on Critical Levels for Plasma Calcium and Bone Mineral Homeostasis (Q37155378) (← links)
• Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts (Q37325555) (← links)
• Review article: vitamin D and inflammatory bowel diseases (Q37413426) (← links)
• A DNA segment spanning the mouse Tnfsf11 transcription unit and its upstream regulatory domain rescues the pleiotropic biologic phenotype of the RANKL null mouse (Q37589815) (← links)
• Role of local vitamin D signaling and cellular calcium transport system in bone homeostasis (Q38161383) (← links)
• Pregnancy in mice lacking the vitamin D receptor: normal maternal skeletal response, but fetal hypomineralization rescued by maternal calcium supplementation (Q38353455) (← links)
• CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. (Q38357169) (← links)
• Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts (Q39076759) (← links)
• Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization (Q39439251) (← links)
• Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways (Q40123747) (← links)
• Characterization of vitamin D receptor immunoreactivity in human bone cells (Q40858551) (← links)
• A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro (Q41017658) (← links)
• [Osteoblastic regulation of osteoclast survival: effect of calcitriol] (Q73360377) (← links)
• From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights (Q90567724) (← links)
• Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial (Q92898222) (← links)
• Vitamin D Inhibition of TRPV5 Expression During Osteoclast Differentiation (Q93052617) (← links)